CHRONIC HEPATITIS B WITH HEPATIC FIBROSIS
Clinical trials for CHRONIC HEPATITIS B WITH HEPATIC FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS B WITH HEPATIC FIBROSIS trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS B WITH HEPATIC FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to help millions with liver damage from hepatitis b
Disease control Not yet recruitingThis study is testing the safety of a higher dose of hydronidone capsules in people with liver scarring (fibrosis) and cirrhosis caused by chronic hepatitis B. 300 adult participants will take the capsules for 28 days and be monitored for side effects. The goal is to gather safet…
Matched conditions: CHRONIC HEPATITIS B WITH HEPATIC FIBROSIS
Phase: PHASE3 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New drug trial aims to tame dangerous liver scarring
Disease control Not yet recruitingThis study is testing the safety of an experimental capsule called hydronidone in people with liver fibrosis (scarring) caused by chronic hepatitis B or fatty liver disease. About 200 participants will take the capsules three times a day for 28 days. The main goal is to see what …
Matched conditions: CHRONIC HEPATITIS B WITH HEPATIC FIBROSIS
Phase: PHASE2 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC